Longitudinal predictive validity of the DSM-5 anxious distress specifier and comorbid generalized anxiety disorder in patients with major depressive disorder.

Longitudinal predictive validity of the DSM-5 anxious distress specifier and comorbid generalized anxiety disorder in patients with major depressive disorder. - Anxious distress and generalized anxiety disorder in depressive patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029417

Enrollment

110

Registered

2017-10-10

Start date

2017-10-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with major depressive disorder who diagnosed bay DSM-5 and taking the same medication during past 3 months.

Exclusion criteria

Exclusion criteria: 1)Patients who contract desease affecting cognitive disfunction, for example epilepsy, alchol dependence syndrome, dementia, organic brain disease and so on. Pregnant patients. 2)Patients who are determined by researchers that the credibility of ther responses cannnot be expected.

Design outcomes

Primary

Measure	Time frame
The prevalence of the DSM-5 anxious distress specifier and generalized anxiety disorder in patients with major depressive disorder.	—

Secondary

Measure	Time frame
Correlation between between the specifier or comorbid generarized anxiety disorder and the severity of depression. Futhermore, the predictive validity of the specifier or cmorbid generalized anxiety disorder was longitudibnal examined for subsequent 6-month chronicity of major depressive disorder.	—

Countries

Japan

Contacts

Public ContactTempei Otsubo

Tokyo Women's Medical University Adachi Medical Center Department of psychiatry

otsubo.tempei@twmu.ac.jp03-3857-0111

Outcome results